Rainov et al., used a herpes simplex virus vector and monocrystalline iron oxide nanoparticles in conjunction with bradykinin-mediated blood–tumor barrier disruption to target gliosarcomas in rats and demonstrated improved uptake and viral-mediated gene delivery [96]. The gene discussed is KNG1; the disease is gliosarcoma.